News Archive

2021

October

Media Release / Oct 14, 2021

Kesimpta® (ofatumumab) data at ECTRIMS highlights preservation of IgG levels and safety experience over extended exposure (~3.5 years) in people living with relapsing multiple sclerosis

Read More
Media Release / Oct 13, 2021

Novartis announces FDA and EMA filing acceptances of BEOVU® for patients with diabetic macular edema

Read More

September

Media Release / Sep 19, 2021

Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer

Read More
Media Release / Sep 17, 2021

Novartis announces findings from a real-world study of alpelisib demonstrating clinical benefit in people with PIK3CA-Related Overgrowth Spectrum (PROS)

Read More

August

Media Release / Aug 31, 2021

Novartis launches "Meet The PROS" to raise awareness and support education for PIK3CA-Related Overgrowth Spectrum (PROS)

Read More
Media Release / Aug 17, 2021

Novartis announces positive results from Phase III trials of BEOVU® in diabetic macular edema, including dosing intervals up to 16 weeks

Read More

July

Featured News / Jul 20, 2021

Beacon of Hope: Addressing health disparities through holistic community-based collective action

Read More
2020

June

Media Release / Jun 16, 2020

Novartis ILARIS® (canakinumab) receives FDA approval for new indication to treat Adult-Onset Still’s Disease (AOSD)

Read More
Media Release / Jun 16, 2020

Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis

Read More
Media Release / Jun 15, 2020

Novartis manufactures and donates 27,000 units of hand sanitizer to New York State

Read More

Related Links